Public Health Emergency: SOLIDARITY TRIAL Philippines
Sponsored by University of the Philippines
About this trial
Last updated 3 years ago
Study ID
SJREB-2020-20
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 4 years ago
What is this trial about?
This study is an adaptive, randomized, open-label, controlled clinical trial utilizing an
adaptive design to compare effects of repurposed drugs with local standard of care alone
on major inpatient hospital outcomes. This is performed worldwide in collaboration with
WHO.
What are the participation requirements?
Inclusion Criteria
- Consenting adults (age ≥18) hospitalised with the following criteria will be included in the study:
1. Probable or confirmed COVID-19 regardless of severity, i.e., mild, moderate and severe cases
2. Not already receiving any of the study drugs
3. Without known allergy or contraindications to any of the study drugs (in the view of the physician responsible for their care), and
4. Without anticipated transfer within 72 hours to a non-study hospital.
Exclusion Criteria
- Patients with contraindications to any of the study drugs.